Search Results - "Halleen, J M"

Refine Results
  1. 1

    Estrogen receptor specificity in the regulation of the skeleton in female mice by Lindberg, MK, Alatalo, SL, Halleen, JM, Mohan, S, Gustafsson, JA, Ohlsson, C

    Published in Journal of endocrinology (01-11-2001)
    “…There are two known estrogen receptors, estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta), which may mediate the actions of estrogen. The…”
    Get full text
    Journal Article
  2. 2

    Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption by Halleen, Jussi M., Alatalo, Sari L., Suominen, Harri, Cheng, Sulin, Janckila, Anthony J., Väänänen, H. Kalervo

    Published in Journal of bone and mineral research (01-07-2000)
    “…Human serum contains two forms of tartrate‐resistant acid phosphatase (TRAP), 5a and 5b. Of these, 5a contains sialic acid and 5b does not. We show here that…”
    Get full text
    Journal Article
  3. 3

    The anti-tumor agent sagopilone shows antiresorptive effects both in vitro and in vivo by Strube, A., Suominen, M. I., Rissanen, J. P., Mumberg, D., Klar, U., Halleen, J. M., Käkönen, S.-M.

    Published in Osteoporosis international (01-11-2011)
    “…Summary Sagopilone, a fully synthetic epothilone and very potent anti-tumor agent, has proved to be efficient in inhibiting bone destruction and tumor burden…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells by Perez-Amodio, S., Vogels, I.M.C., Schoenmaker, T., Jansen, D.C., Alatalo, S.L., Halleen, J.M., Beertsen, W., Everts, V.

    Published in Bone (New York, N.Y.) (01-06-2005)
    “…Tartrate-resistant acid phosphatase (TRACP) is produced by macrophages and other cells of the monohistiocytic lineage. In particular, osteoclasts are…”
    Get full text
    Journal Article
  7. 7

    Serum TRACP 5b and ICTP as Markers of Bone Metastases in Breast Cancer by KORPELA, J, TIITINEN, S. L, HIEKKANEN, H, HALLEEN, J. M, SELANDER, K. S, VÄÄNÄNEN, H. K, SUOMINEN, P, HELENIUS, H, SALMINEN, E

    Published in Anticancer research (01-07-2006)
    “…Background: The purpose of this cross-sectional study was to evaluate the value of serum tartrate-resistant acid phosphatase 5b (TRACP 5b) and carboxyterminal…”
    Get full text
    Journal Article
  8. 8

    Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium by Alatalo, Sari L, Halleen, Jussi M, Hentunen, Teuvo A, Monkkonen, Jukka, Vaananen, H. Kalervo

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2000)
    “…Osteoclasts secrete tartrate-resistant acid phosphatase (TRAP; EC 3.1.3.2) 5b into the circulation. We studied the release of TRAP 5b from osteoclasts using a…”
    Get full text
    Journal Article
  9. 9

    Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer by Salminen, Eeva, Ala-Houhala, M, Korpela, J, Varpula, M, Tiitinen, S L, Halleen, J M, Väänänen, H K

    Published in Acta oncologica (2005)
    “…Skeletal metastases are a significant problem in prostate cancer (PC). The patients are also exposed to treatment-related skeletal changes. This…”
    Get more information
    Journal Article
  10. 10

    Clinical Significance of Immunoassays for Type-5 Tartrate-resistant Acid Phosphatase by Nakasato, Yuri R, Janckila, Anthony J, Halleen, Jussi M, Vaananen, H. Kalervo, Walton, Stephanie P, Yam, Lung T

    Published in Clinical chemistry (Baltimore, Md.) (01-12-1999)
    “…Tartrate-resistant acid phosphatase (TRAP; EC 3.1.3.2) is a product of osteoclasts and a biochemical marker of bone resorption rate. However, erythrocytes and…”
    Get full text
    Journal Article
  11. 11

    The cell biology of osteoclast function by Väänänen, H K, Zhao, H, Mulari, M, Halleen, J M

    Published in Journal of cell science (01-02-2000)
    “…Osteoclasts are multinucleated cells responsible for bone resorption. They have developed an efficient machinery for dissolving crystalline hydroxyapatite and…”
    Get full text
    Journal Article
  12. 12

    Characterization of Serum Tartrate‐Resistant Acid Phosphatase and Development of a Direct Two‐Site Immunoassay by Halleen, Jussi M., Hentunen, Teuvo A., Karp, Matti, Käkönen, Sanna‐Maria, Pettersson, Kim, Väänänen, H. Kalervo

    Published in Journal of bone and mineral research (01-04-1998)
    “…Osteoclasts secrete tartrate‐resistant acid phosphatase (TRAP) to the circulation, where the amount of TRAP is expected to correlate with the bone resorption…”
    Get full text
    Journal Article
  13. 13

    Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women by Gerdhem, Paul, Ivaska, Kaisa K, Alatalo, Sari L, Halleen, Jussi M, Hellman, Jukka, Isaksson, Anders, Pettersson, Kim, Väänänen, H Kalervo, Åkesson, Kristina, Obrant, Karl J

    Published in Journal of bone and mineral research (01-03-2004)
    “…We studied the ability of various markers of bone turnover to predict fracture in 1040 randomly recruited 75‐year‐old women. A total of 178 of the women…”
    Get full text
    Journal Article
  14. 14

    Two‐Site Immunoassays for Osteoclastic Tartrate‐Resistant Acid Phosphatase Based on Characterization of Six Monoclonal Antibodies by Halleen, Jussi M., Karp, Matti, Viloma, Sari, Laaksonen, Pirjo, Hellman, Jukka, Käkönen, Sanna‐Maria, Stepan, Jan J., Holmes, Stephen, Väänänen, H. Kalervo, Pettersson, Kim

    Published in Journal of bone and mineral research (01-03-1999)
    “…Tartrate‐resistant acid phosphatase (TRAP), an enzyme expressed in bone‐resorbing osteoclasts, is secreted into the circulation during bone resorption. We used…”
    Get full text
    Journal Article
  15. 15

    Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover by Nenonen, Arja, Cheng, Sulin, Ivaska, Kaisa K, Alatalo, Sari L, Lehtimäki, Terho, Schmidt‐Gayk, Heinrich, Uusi‐Rasi, Kirsti, Heinonen, Ari, Kannus, Pekka, Sievänen, Harri, Vuori, Ilkka, Väänänen, H Kalervo, Halleen, Jussi M

    Published in Journal of bone and mineral research (01-10-2005)
    “…We studied clinical performance of serum TRACP 5b and other bone turnover markers, including S‐CTX, U‐DPD, S‐PINP, S‐BALP, and S‐OC, for monitoring alendronate…”
    Get full text
    Journal Article
  16. 16

    Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts by Vääräniemi, Jukka, Halleen, Jussi M, Kaarlonen, Katja, Ylipahkala, Hannele, Alatalo, Sari L, Andersson, Göran, Kaija, Helena, Vihko, Pirkko, Väänänen, H Kalervo

    Published in Journal of bone and mineral research (01-09-2004)
    “…In osteoclasts, TRACP co‐localized with cathepsin K in transcytotic vesicles and was activated by cathepsin K in vitro, suggesting that TRACP may degrade…”
    Get full text
    Journal Article
  17. 17

    Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density by Halleen, J M, Ylipahkala, H, Alatalo, S L, Janckila, A J, Heikkinen, J E, Suominen, H, Cheng, S, Väänänen, H K

    Published in Calcified tissue international (01-07-2002)
    “…Human serum contains two isoforms of tartrate-resistant acid phosphatase (TRACP) known as TRACP 5a and TRACP 5b with pH optima of 5.0 and 5.8, respectively…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Potential Function for the ROS‐Generating Activity of TRACP by Halleen, Jussi M, Räisänen, Seija R, Alatalo, Sari L, Väänänen, H Kalervo

    Published in Journal of bone and mineral research (01-10-2003)
    “…TRACP is an enzyme with unknown biological function. It is expressed primarily in bone‐resorbing osteoclasts and activated macrophages. In addition to its…”
    Get full text
    Journal Article